Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» heart failure
heart failure
Abbott Gets to the Heart of Extending Life-Expectancy with HeartMate 3 Data
Medical Devices and Diagnostics Industry
Tue, 08/30/22 - 11:59 am
Abbott Labs
devices
Medtech
heart failure
HeartMate 3
AstraZeneca’s Farxiga reduces CV mortality risk in Phase III trials
Clinical Trials Arena
Mon, 08/29/22 - 11:01 am
AstraZeneca
Farxiga
clinical trials
heart failure
Cytokinetics aims to become the Vertex of cardiovascular disease
EP Vantage
Thu, 06/16/22 - 10:19 am
Cytokinetics
Amgen
heart failure
Omecamtiv Mecarbil
cardiovascular disease
Will third time be the charm? Lexicon finally refiles SGLT2 drug for heart failure
Endpoints
Tue, 05/31/22 - 11:58 pm
Lexicon Pharmaceuticals
sotagliflozin
heart failure
FDA
AZ bites back at rivals with new Farxiga data in heart failure
Pharmaforum
Thu, 05/5/22 - 10:16 am
AstraZeneca
Farxiga
heart failure
clinical trials
CEO of cardiology startup declares that its tech could potentially cure heart failure
MedCity News
Sat, 04/30/22 - 02:30 pm
Ceryx
cardiology
startups
heart failure
Medtech
devices
Cysoni
ACC: Lexicon hopes sotagliflozin cardio data will set its drug apart from SGLT2 rivals
Fierce Pharma
Mon, 04/4/22 - 10:59 am
Lexicon Pharmaceuticals
ACC
diabetes
sotagliflozin
type 2 diabetes
heart failure
Eli Lilly, Boehringer Ingelheim's Jardiance turns up heat on AstraZeneca's Farxiga with broad EU heart failure approval
Fierce Pharma
Mon, 03/7/22 - 10:10 am
Eli Lilly
Boehringer Ingelheim
Jardiance
heart failure
Europe
AstraZeneca
Farxiga
Eli Lilly, Boehringer Ingelheim's Jardiance clinches heart failure edge with FDA nod for wider label
Fierce Pharma
Fri, 02/25/22 - 10:24 am
Eli Lilly
Boehringer Ingelheim
Jardiance
heart failure
FDA
How Abbott’s Newest Indication Is Reshaping Heart Failure Management
Medical Devices and Diagnostics Industry
Thu, 02/24/22 - 10:58 pm
Abbott Labs
CardioMEMS
heart failure
devices
Medtech
Taking on Big Pharma-sized indications, tiny biotech claims early win in fat loss. Will it translate to diabetes, NASH and beyond?
Endpoints
Wed, 02/9/22 - 10:01 am
Rivus Pharmaceuticals
diabetes
NASH
heart failure
Cytokinetics hopes to resurrect omecamtiv
EP Vantage
Wed, 01/19/22 - 11:08 am
Cytokinetics
Omecamtiv Mecarbil
heart failure
Abandoned by Amgen, Cytokinetics lands $50M upfront deal for Chinese rights to heart failure prospect
Fierce Biotech
Tue, 12/21/21 - 10:34 am
Cytokinetics
heart failure
Omecamtiv Mecarbil
Amgen
China
Ji Xing Pharmaceuticals
Could Moderna and AstraZeneca's mRNA Heart Failure Drug Candidate Be a Winner?
Motley Fool
Sun, 12/5/21 - 10:47 pm
Moderna Therapeutics
AstraZeneca
AZD-8601
heart failure
MRNA
Moderna, AstraZeneca announce positive AZD8601 data from Phase 2 study in heart failure
Seeking Alpha
Mon, 11/15/21 - 12:27 pm
Moderna Therapeutics
MRNA
AstraZeneca
clinical trials
heart failure
J&J looks to toss its SGLT2 hat in the ring for two types of heart failure
Endpoints
Sun, 11/14/21 - 10:47 pm
JNJ
Invokana
heart failure
clinical trials
Boehringer-Lilly’s Jardiance obtains FDA priority review to treat heart failure
Pharmaceutical Business Review
Fri, 11/12/21 - 10:37 am
Eli Lilly
Boehringer Ingelheim
Jardiance
priority review
FDA
heart failure
Heart Failure Patients Take Heart as Carmat’s Bioprosthetic Implanted into First Woman
BioSpace
Thu, 09/23/21 - 11:00 am
Carmat
heart failure
Artificial Heart
Medtech
devices
Abbott seeks expanded indication, national coverage for CardioMEMS device
MedCity News
Sat, 09/18/21 - 08:19 pm
Abbott Labs
FDA
devices
CardioMEMS
heart failure
CMS
COVID-19 seems to skew Abbott heart failure monitor study results
Medtech Dive
Mon, 08/30/21 - 11:45 pm
Abbott Labs
heart failure
COVID-19
clinical trials
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »